Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations

LC Tao, J Xu, T Wang, F Hua, JJ Li - Cardiovascular diabetology, 2022 - Springer
The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker
of insulin resistance (IR). Recently, a considerable number of studies have provided robust …

Cardiac MRI: state of the art

PS Rajiah, CJ François, T Leiner - Radiology, 2023 - pubs.rsna.org
Cardiac MRI plays an important role in the evaluation of cardiovascular diseases (CVDs),
including ischemic heart disease, cardiomyopathy, valvular disease, congenital disease …

Empagliflozin reduces myocardial extracellular volume in patients with type 2 diabetes and coronary artery disease

T Mason, OR Coelho-Filho, S Verma… - Cardiovascular …, 2021 - jacc.org
Objectives This study sought to evaluate the effects of empagliflozin on extracellular volume
(ECV) in individuals with type 2 diabetes mellitus (T2DM) and coronary artery disease …

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

BA Maron, RS Wang, S Shevtsov, SG Drakos… - Nature …, 2021 - nature.com
Progress in precision medicine is limited by insufficient knowledge of transcriptomic or
proteomic features in involved tissues that define pathobiological differences between …

Myocardial characterization with extracellular volume mapping with a first-generation photon-counting detector CT with MRI reference

GJ Aquino, J O'Doherty, UJ Schoepf, B Ellison, J Byrne… - Radiology, 2023 - pubs.rsna.org
Background Photon-counting detector (PCD) CT provides comprehensive spectral data with
every acquisition, but studies evaluating myocardial extracellular volume (ECV) …

Multimodality imaging assessment of myocardial fibrosis

S Gupta, Y Ge, A Singh, C Gräni, RY Kwong - Cardiovascular Imaging, 2021 - jacc.org
Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …

Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association …

B Moura, A Aimo, A Al‐Mohammad… - European Journal of …, 2023 - Wiley Online Library
Left ventricular (LV) hypertrophy consists in an increased LV wall thickness. LV hypertrophy
can be either secondary, in response to pressure or volume overload, or primary, ie not …

Characterizing the heart and the myocardium with photon-counting CT

E Zsarnóczay, A Varga-Szemes, T Emrich… - Investigative …, 2023 - journals.lww.com
Noninvasive cardiac imaging has rapidly evolved during the last decade owing to
improvements in computed tomography (CT)–based technologies, among which we …

Diabetes and myocardial fibrosis: a systematic review and meta-analysis

DB Salvador Jr, MR Gamba, N Gonzalez-Jaramillo… - Cardiovascular …, 2022 - jacc.org
Objectives This systematic review and meta-analysis investigated the association of
diabetes and glycemic control with myocardial fibrosis (MF). Background MF is associated …

Myocardial fibrosis: why image, how to image and clinical implications

R Bing, MR Dweck - Heart, 2019 - heart.bmj.com
The current era has seen major advances in myocardial imaging. We are now able to
assess cardiac anatomy, function, tissue composition and disease activity across a wide …